Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(4.19)
# 482
Out of 5,111 analysts
387
Total ratings
45.5%
Success rate
17.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASMB Assembly Biosciences | Assumes: Buy | $50 | $34.60 | +44.51% | 1 | Aug 18, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $5.28 | +127.27% | 19 | Aug 13, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $500 → $570 | $391.50 | +45.59% | 27 | Aug 7, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $45 → $40 | $6.59 | +506.98% | 17 | Aug 4, 2025 | |
| ATAI Atai Beckley | Maintains: Buy | $10 → $15 | $4.14 | +262.32% | 20 | Jul 30, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $17.03 | -41.28% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $2.22 | +125.23% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.44 | +2,172.73% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $6.60 | +1,036.36% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $36.02 | +177.62% | 21 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $20.43 | +242.63% | 15 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.92 | +441.71% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $4.80 | +1,150.00% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $68.45 | +16.87% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $12.49 | +220.38% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.36 | +588.07% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $38.92 | +79.86% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $26.83 | +198.17% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $2.35 | +326.44% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.79 | +163.85% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $12.08 | +355.30% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $6.72 | +1,536.90% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $85.67 | -0.78% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $150 | $6.66 | +2,152.25% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $12.18 | +458.29% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $151.06 | +125.08% | 1 | Aug 18, 2021 |
Assembly Biosciences
Aug 18, 2025
Assumes: Buy
Price Target: $50
Current: $34.60
Upside: +44.51%
Altimmune
Aug 13, 2025
Reiterates: Buy
Price Target: $12
Current: $5.28
Upside: +127.27%
Alnylam Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $500 → $570
Current: $391.50
Upside: +45.59%
COMPASS Pathways
Aug 4, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $6.59
Upside: +506.98%
Atai Beckley
Jul 30, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $4.14
Upside: +262.32%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $17.03
Upside: -41.28%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $2.22
Upside: +125.23%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.44
Upside: +2,172.73%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $6.60
Upside: +1,036.36%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $36.02
Upside: +177.62%
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $20.43
Upside: +242.63%
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $0.92
Upside: +441.71%
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $4.80
Upside: +1,150.00%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $68.45
Upside: +16.87%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $12.49
Upside: +220.38%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $4.36
Upside: +588.07%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $38.92
Upside: +79.86%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $26.83
Upside: +198.17%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $2.35
Upside: +326.44%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $3.79
Upside: +163.85%
Mar 7, 2025
Reiterates: Buy
Price Target: $55
Current: $12.08
Upside: +355.30%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $6.72
Upside: +1,536.90%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $85.67
Upside: -0.78%
Feb 13, 2025
Maintains: Buy
Price Target: $190 → $150
Current: $6.66
Upside: +2,152.25%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $12.18
Upside: +458.29%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $151.06
Upside: +125.08%